Literature DB >> 9573459

Delivery of total parenteral nutrition (TPN) via umbilical catheterization: development of a piglet model to investigate therapies to improve gastrointestinal structure and enzyme activity during TPN.

Y K Park1, M M Monaco, S M Donovan.   

Abstract

Nutritional support of preterm infants by total parental nutrition (TPN) is common; however, TPN compromises intestinal structure and enzyme activity. Our goal was to develop a piglet model to assess the effect of limited enteral stimulation with formula and insulin-like growth factor-I (IGF-I) on intestinal morphology and enzyme activity. A nutritionally complete TPN solution was infused for 7 days and piglets were gavaged twice daily with 4 ml sterile water, formula, or formula containing 1,000 micrograms/l IGF-I. Litter mate piglets fed formula served as orally fed controls. On day 7, body weights and plasma hormone profiles of TPN and orally fed piglets were similar. However, intestinal weight, jejunal and ileal villus height and surface area, and mucosal lactase and sucrase activity of TPN piglets was reduced by approximately 50%. No effect of limited enteral stimulation or IGF-I was observed likely due to the small volume of formula administered enterally, which resulted in a low dose of IGF-I (4.3 micrograms IGF-I/kg/day).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573459     DOI: 10.1159/000013988

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  2 in total

1.  Rearing environment affects development of the immune system in neonates.

Authors:  C F Inman; K Haverson; S R Konstantinov; P H Jones; C Harris; H Smidt; B Miller; M Bailey; C Stokes
Journal:  Clin Exp Immunol       Date:  2010-02-22       Impact factor: 4.330

2.  Short-term fasting induces intra-hepatic lipid accumulation and decreases intestinal mass without reduced brush-border enzyme activity in mink (Mustela vison) small intestine.

Authors:  C R Bjornvad; J Elnif; P T Sangild
Journal:  J Comp Physiol B       Date:  2004-10-20       Impact factor: 2.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.